Skip to content

A study to assess food intake sarcopenic obesity and other outcomes of treatment in Indian children having acute lymphoblastic leukemia (blood cancer)

Dietary intake, sarcopenic obesity, and other treatment-related outcomes in Indian children with acute lymphoblastic leukemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/013324
Enrollment
500
Registered
2018-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children with Acute lymphoblastic leukemia

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital Research Administration Council
Lead Sponsor
Dr Elena J Ladas
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed ALL; 2. Able to consume >= 80% of dietary requirements enterally; 3. Adequate performance status (Lansky score >=70); receiving standard treatment for ALL on or as per the Indian Childhood Collaborative Leukemia Groupâ??s protocol (ICiCLe).

Exclusion criteria

Exclusion criteria: 1. Refusal of consent; 2. Relapsed ALL; 3. Downs syndrome; 4. Therapy initiated elsewhere

Design outcomes

Primary

MeasureTime frame
1. Nutritional Anthropometrics 2.Dietary Intake 3. Food Record 4.Medical Nutrition Support (MNS) 5. Fat Mass (FM) and Fat-Free Mass (FFM) and Definition of Sarcopenic Obesity 6. Assessment of Physical Activity (PA)Timepoint: At the time of diagnosis when you first come to the hospital, at about one month after diagnosis, 6 months after diagnosis and one year after diagnosis.

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactDr Maya Prasad

Tata Memorial Hospital

maya.prasad@gmail.com9819379113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026